Sign in →

Test Code HEP ACUTE Acute Hepatitis Panel

Additional Codes

LAB551

Collection Method

Venous collection

Minimum Volume

8ml

Container

Gold Top SST

Acceptable Specimens

Gold Top SST

Reference or Target Ranges

Hepatitis A Antibody IgM (HAV M) Nonreactive
Hepatitis B Core Antibody IgM (HBcAb M) Nonreactive
Hepatitis B Surface Antigen (HBsAg) Nonreactive
Hepatitis C Antibody (HCV) with reflex Nonreactive

Reasons for Rejection

Hemolysis Threshold See individual assays
Icterus Threshold See individual assays
Lipemia Threshold See individual assays
Other QNS, contaminated, improperly Labeled, improper specimen type

Specimen Stability

Ambient See individual assays
Refrigerated (4°C to 8°C) See individual assays
Frozen(-40°C to 0°C) See individual assays

Performance Information

Days and Time Performed 24/7
Expected Turn Around Time

Stat: 1 hour

Routine:  4 hours

Stat Availability Yes
Performing Bench CPH Chemistry
Methodology/Method Description Roche Cobas 

Result Interpretation

 

Hepatitis A Antibody IgM (HAV M)  
Nonreactive IgM antibodies to Hepatitis A Virus were not detected. This does not exclude the possibility of exposure to, or infection with HAV. Levels of IgM antibodies to HAV may be below the cut-off in early infection.
Borderline IgM antibodies to Hepatitis A may or may not be present. Patients exhibiting borderline test results should be closely monitored by redrawing and retesting at approximately two week intervals.
Reactive IgM antibodies to Hepatitis A Virus detected. This is presumptive evidence of HAV infection. A Reactive IgM antibody to HAV does not rule out other hepatitis infections.
Hepatitis B Core Antibody IgM (HBcAb M)  
Nonreactive IgM antibodies to Hepatitis B Core were not detected. This does not exclude the possibility of prior exposure to, or infection with hepatitis. Levels of antibodies to hepatitis B core may be below the cut-off in early infection.
Reactive IgM antibodies to Hepatitis B core detected. This is presumptive evidence of acute infection or acute attack in an individual with chronic hepatitis B infection. A Reactive hepatitis B core antibody does not rule out other hepatitis infections. The specimen will be forwarded to Mayo Medical Laboratories for confirmatory testing.
Hepatitis B Surface Antigen (HBsAg)  
Nonreactive Hepatitis B surface antigen was not detected. This does not exclude the possibility of exposure to, or infection with Hepatitis B Virus.
Reactive This test is intended as a screen only. A reactive result indicates presumptive evidence of infection with HBV. The specimen will be forwarded to Mayo Medical Laboratories for confirmatory testing. 
Specimens with reactive screen results but negative (ie, not confirmed) HBsAg confirmatory test results are likely to contain cross-reactive antibodies from other infectious or immunologic disorders. Repeat testing is recommended at a later date if clinically indicated. 
Hepatitis C Antibody (HCV) with reflex  
Nonreactive Antibodies to HCV were not detected; this does not exclude the possibility of exposure to HCV.
Reactive This test is intended as a screen only. A reactive result indicates presumptive evidence of antibodies to HCV. The specimen will be forwarded to Mayo Medical Laboratories for confirmatory testing.

 

 

CPT Codes

80074

Last review/edit date

2025